S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CARA Cara Therapeutics Inc

0.4636

0.0062 (1.36%)

25 Dec 2024 - Closed

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Cara Therapeutics Charts.

Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Cara Therapeutics Charts.

Cara Therapeutics Inc News

Form 425 - Prospectuses and communications, business combinations
Saturday 21 December 2024 (5 days ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Saturday 21 December 2024 (5 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 19 December 2024 (1 week ago) • Edgar (US Regulatory)

Form S-4 - Registration of securities, business combinations
Thursday 19 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Wednesday 18 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 18 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 23 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Thursday 31 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 15 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 2 August 2024 (5 months ago) • Edgar (US Regulatory)

More Cara Therapeutics Inc News Articles

Verizon Communications

Commonwealth Bank Of Aus...

Invesco QQQ Trust Series 1

JP Morgan Chase

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions